Focus: Bio-Tissue specializes in amniotic membrane-based therapies for regenerative medicine and wound care applications. The company operates as a focused biotechnology player headquartered in Miami with a commercial-stage portfolio.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Cooling — net -5 jobs in 30d
5 added, 10 removed. Slower than typical.
Bio-Tissue is a fit for commercial-track professionals seeking growth in a niche regenerative medicine space, but presents execution risk for R&D-focused careers due to thin pipeline visibility and data opacity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Bio-Tissue
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Bio-Tissue's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo